How I'm Learning to Outlive My Mother
Happy photos like this one, which is protected in a heart-shaped frame, decorate the shelves in my home office. The sadder ones — taken after my mother was diagnosed with metastatic breast cancer — hide inside my desk drawers.
They're out of sight, but the truth is, they're always on display in my mind. They sit alongside the many journals in which my mother kept track of my childhood accomplishments and made predictions about my future. 'Mallary's going to go places with her writing,' she wrote in one of them, believing I would one day become an author. 'I'm so proud of her.'
My mom passed away from cancer when I was 11, before she could see me graduate middle school, let alone go off to college, pursue a writing career, get married, and have kids.
She was just 40 years old when she died — the same age I am now. As I begin to outlive my mother, I've been pondering questions that lack easy answers: How do I venture into this next phase of life that she never got to experience? What are the lessons she taught me (and didn't get to teach) that I want to pass on to my own children? And how can I continue to keep my mom's memory alive?
On my 40th birthday, I told my 7-year-old son and 9-year-old daughter why this particular birthday was so significant. They've heard me share stories about my mother for years, but this was the first time they learned how old she'd been when she passed away.
'Just because your mom died when you were 40 doesn't mean you're going to, right, Mommy?' my daughter asked, making my heart sink.
'Oh no honey, I'm not going to die at 40,' I reassured her. 'My mother was sick, but I'm not. I hope to be around for a loooong time.' My words were tightly woven together by years of convincing myself that I won't die young. And yet I know the unpredictability of life could unravel these words at any point, rendering them a lie in my children's minds.
I hope my words remain true, but the reality of mortality seems to loom larger now that I'm 40. In some ways it's a relief to have outlived my mother, because it feels like a sign that my fate will not follow hers. But I also find myself wondering: How much longer do I really have?
Grief expert Hope Edelman once told me that when you begin to outlive your deceased parent, you are 'crossing the silent threshold.' When experiencing this rite of passage, she said, it's normal to grow fearful about dying and/or to experience mourning anew. Edelman recommends honoring the silent threshold by naming it and recognizing what surfaces.
If growing up meant living without my mother, then I wanted to stay in the past forever.
I've been recognizing it by going through the photos in my desk drawers and exposing the hard truths behind them. There's one in particular that I keep returning to — a picture of me looking happy as can be just five days after my mother's death. I was at my first-ever middle school dance, smiling and looking perfectly poised, like a ballerina about to do a pirouette. I thought I was supposed to be 'strong' and 'resilient,' so I tried pretending to be okay. But behind that happy facade was a little girl who felt like her whole world had fallen apart.
If growing up meant living without my mother, then I wanted to stay in the past forever. I remember doing the math as I got ready for the dance, counting out exactly how many hours and minutes had passed since my mother died; they say time heals, but I learned at a young age that time also hurts. Every birthday, holiday, and missed milestone became a painful reminder of the permanence of my mother's absence.
When you lose a parent at a young age, you're always playing a game of catch-up that reminds you of not just who you've lost but what you've lost — all those life lessons that you hope your mom would have shared to help you navigate the world.
Having lost my mother just before my teenage years, I found it especially difficult to navigate puberty without her. I wanted her to teach me everything I thought a teenage girl was supposed to learn: how to use an eyelash curler, shop for bras, insert a tampon, and shave my legs.
I feel a pang whenever I look at one close-up photo of me as a 14-year-old, with eyelashes that were clumped together by far too much Maybelline mascara. I had taught myself how to apply it, hoping that it would help me look more like my mom, who had always worn it until she got too sick and weak to put it on.
But it wasn't until age 38 that I learned how to properly use an eyelash curler. I had always applied my mascara and then curled my lashes, until one day a friend told me I was supposed to do it the other way around. How did I not know that? I thought to myself, feeling the load of loss grow heavier.
Soon enough, when my lip-gloss-loving daughter expresses interest in makeup, I will show her how the curler works. Until then, I'm trying to teach my kids the bigger life lessons that my mom shared with me when I was young: how to persevere in the face of uncertainty, work hard for what you want, and show familial love.
Lately I've felt a greater sense of urgency around sharing these lessons, especially when I think about what else is hiding in my desk drawers: genetic test results showing that, as my mother's daughter, I'm at a higher risk of developing breast cancer compared to other women my age.
As I enter midlife, it saddens me to know that my mom never got to witness all the places I've gone with my writing — and that she won't get to celebrate alongside me when my debut memoir is published this summer. But I find comfort in knowing that she was there from the very start, believing in me and giving me reason to feel hopeful about the future.
Mallary Tenore Tarpley is a journalism professor at the University of Texas at Austin and author of the memoir SLIP.
The post How I'm Learning to Outlive My Mother appeared first on Katie Couric Media.
Solve the daily Crossword

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers
DALLAS, Aug. 6, 2025 /PRNewswire/ -- iCRYO, a leading health, wellness, and longevity franchise, is excited to announce that its CEO and Co-Founder, Kyle Jones, and Chief Administrative Officer (CAO), Scott Briner, will be featured speakers at the Vitality Business Summit 2025. The summit, scheduled for October 3-5, 2025, at the Hilton DFW Lakes Executive Conference Center in Dallas, Texas, is organized and hosted by brothers Chris and Brad Himel of Himel Health, longtime consultants for health and wellness clinics. Leveraging their network, they are bringing together brand entrepreneurs, clinic owners, and other health enthusiasts to shape the future of health and wellness. Emphasizing practical solutions over passing trends, The Vitality Business Summit promises to equip attendees with the tools to build scalable, purpose-driven businesses. Kyle W. Jones, as a pioneer in cryotherapy and holistic wellness going back to 2015, will join a host of other accomplished leaders in the industry, including acclaimed speaker and author Tim Storey, motivational speaker Jenn Drummond, BrainTap founder Dr. Patrick Porter, business coach Raquel Diehm, and OxyHealth CEO Dr. Mayur Patel, to name a few. "I'm thrilled to speak at the Vitality Business Summit and share the strategies that have fueled iCRYO's growth while keeping wellness accessible," said Jones. "At the same time, this event is a catalyst for change, with innovation and adoption moving ever faster in this space. This summit offers us a chance to keep our finger on the pulse and connect with other professionals building businesses that will make a lasting impact." iCRYO's CAO and former hospital CEO Scott Briner echoed Jones' thoughts, adding, "I'm honored to join Kyle as a speaker and represent iCRYO at the Vitality Business Summit this fall. We've developed what we believe is the new industry-standard for medical care in a retail environment, and we're proud to share it with the world any chance we get. However, we're always looking to learn, grow, and improve iCRYO's service and offerings, and this event gives us that chance." The summit caters to a diverse audience, from solo practitioners to multi-unit clinic owners, offering unparalleled opportunities to learn sales and marketing frameworks used by successful clinics, network with world-class experts, explore dozens of vendors showcasing the latest in wellness modalities and therapies, develop a tailored growth plan, and create lasting partnerships. Early Bird pricing offers up to 50% off General Admission and 33% off VIP tickets, which include a VIP Lunch with speakers on Sunday. Attendees are encouraged to secure their spots now as both General Admission and VIP tickets are going fast with these early bird offers. Event Details: Date: October 3-5, 2025 Location: Hilton DFW Lakes Executive Conference Center, Dallas, Texas Tickets: Available at About iCRYO Founded in 2015, iCRYO's mission is to elevate the quality of life of its team members, guests, and franchisees by providing affordable, professional, and convenient personal health services while raising the standard as a global wellness brand. To learn more about its services, locations, and franchise opportunities, visit iCRYO Media Contact Robbie JenkinsDirector of View original content to download multimedia: SOURCE iCRYO Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Washington Post
20 minutes ago
- Washington Post
RFK Jr.'s slander of mRNA technology will harm Americans
Robert F. Kennedy Jr.'s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA technology underscores perhaps the greatest harm that he might inflict on the nation with his anti-vaccine ideology. The disparagement of existing immunizations by the health and human services secretary is dangerous on its own, in that it might persuade people to forego recommended shots and reduce herd immunity against diseases. But potentially even worse are the impacts that will be harder to see: the diseases that public health officials won't be able to fight because of the lifesaving innovations he is cutting short. Kennedy's resistance against mRNA vaccines is without evidence. In fact, the technology — which instructs the body's cells to produce a harmless bit of virus that is then used to train the immune system, as opposed to using weakened or dead versions of a virus — delivered arguably the most important achievement of President Donald Trump's first term: the production of effective vaccines against the novel coronavirus within the span of a few months. Such speed was practically unheard-of in biomedical research. Thanks to the urgency created by Operation Warp Speed, the federal government was able to mount an impressive vaccination rollout that boosted the population's immunity to the coronavirus just when it was needed. As with any medical treatment, these vaccines were not perfect. In very rare instances among adolescents, they resulted in a serious side effect known as myocarditis, or inflammation of the heart muscle. Their effectiveness also waned over time as the coronavirus mutated, as is the case with vaccines for other respiratory diseases. But there can be no doubt: These vaccines saved millions of lives. Kennedy absurdly claimed in a video statement that 'mRNA vaccines don't perform well against viruses that infect the upper respiratory tract.' He further claimed that a single mutation in a virus can render vaccines 'ineffective.' He even went so far as to argue that this effect 'encourages' mutations and could 'prolong' a pandemic. This is just plain wrong, as the covid pandemic demonstrated. The effectiveness of mRNA coronavirus vaccines might have diminished over time, but they continued to protect people against severe illness over the course of multiple strains. In fact, the Centers for Disease Control and Prevention continued to recommend the shots for vulnerable populations for that reason, and manufacturers updated boosters to combat new strains. Giving up on this game-changing technology will slow down scientific innovation, leaving Americans more vulnerable to diseases. Kennedy just canceled or altered 22 mRNA projects that were supported by the Biomedical Advanced Research and Development Authority. On the chopping block are vaccine developments for several respiratory illnesses. That includes a project to defend the country against the H5N1 bird flu virus, which scientists warn could spiral into a deadly pandemic if someone contracts it while also infected with the seasonal flu virus. And that's just the beginning. Researchers are eager to deploy mRNA technology against a slew of other hard-to-tackle pathogens, from hepatitis C to HIV to malaria. There are even efforts to use this approach to activate the immune system to attack cancer cells and to treat other genetic diseases. Some scientists have suggested this research could also be essential for national security, as it might help defend against attacks from biological weapons. Calling Kennedy's latest actions shortsighted understates the gravity of his slander. Americans will bear the cost of his rejection of science.


Forbes
20 minutes ago
- Forbes
USAID And PEPFAR Cuts Could Lead To Massive Loss Of Life Overseas
A Lancet paper published in July evaluates data to illustrate the importance of roughly two decades of American humanitarian aid offered through the United States Agency for International Development and the President's Emergency Plan for AIDS Relief. The piece subsequently projects what the future could look like in light of the steep cuts imposed by President Trump to USAID and PEPFAR. Authors estimate that USAID-funded programs have helped prevent more than 91 million deaths globally in the past 20 years, including 30 million fatalities among children. Projections suggest that ongoing deep funding cuts—combined with the dismantling of the agency—could result in more than 14 million additional deaths by 2030. On inauguration day, President Trump ordered a sweeping 90-day spending freeze on virtually all U.S. foreign aid, including many forms of health and food assistance. An independent agency, USAID, was largely gutted. The USAID undertakes a wide range of activities, which include among other things food aid and distribution (often in conflict zones), clean water provision, maternal and infant health support, mass administration of rehydration salts for children suffering from diarrhea, malaria prevention and treatments and polio vaccinations in countries where the disease is still endemic. The agency was established under President John F. Kennedy in the early 1960s to administer humanitarian aid programs around the world. Congress appropriates funds for USAID's operations. The agency employed roughly 10,000 people, two-thirds of whom worked overseas. In fiscal year 2024, the agency received more than $44 billion in federal funding. Most of that money was spent in Asia, sub-Saharan Africa and Europe (primarily on humanitarian efforts in Ukraine). While a considerable sum, it merely accounts for 0.4% of the entire federal budget. The Trump administration has slashed 86% of USAID funding. Only a small fraction of aid programs remains in place. The employee head count is now under 500. As carried out by successive administrations since Bush, including the first Trump administration, PEPFAR represented the largest commitment in history by any nation to address a single disease, HIV/AIDS. But gradually the second Trump administration is unraveling this initiative, too. KFF reported that while PEPFAR received a limited waiver on Feb. 1, allowing it to continue certain 'life-saving HIV services,' the waiver doesn't include essential pre-exposure prophylaxis for anyone other than pregnant and breastfeeding women. The State Department has sought $2.9 billion in funding to continue HIV-AIDS programs in the next fiscal year—considerably lower than PEPFAR's current budget of $4.1 billion. Moreover, USAID was the main agency working on behalf of PEPFAR. Without USAID and its staff, PEPFAR's implementation capacity has been seriously affected. Going forward, the Trump administration intends to transform PEPFAR from an aid program to one that is aligned with its 'America First' priorities. The plan, as described by the New York Times, outlines the administration's intentions to 'transition' countries off of PEPFAR, in some cases within two years. The program would in essence no longer be involved in aid and saving lives overseas. Rather, it would focus on detecting outbreaks that could threaten the U.S. and at the same time create new markets for American drugs and technologies. On the ground, journalists are painting a grim picture of the implications of the drastic curtailment in U.S. aid. A story in America Magazine, for example, describes in detail the local impact in Eswatini, a country in Southern Africa, of the gutting of USAID and reductions in PEPFAR. Cuts have severely limited access to HIV treatments and testing in clinics. During the height of the HIV/AIDS pandemic, the population of Eswatini plummeted, and life expectancy dropped from 61 in 1988 to 44 by 2003. It reverted to 61 in 2023, thanks in large part to USAID and PEPFAR. But now the gains in health outcomes are in jeopardy. The ramifications of a greatly diminished U.S. presence in health aid, international development and disaster assistance could be profound, specifically around the global humanitarian programs which rely on USAID. In terms of international assistance, the U.S. was by far the world's largest donor. The U.S. spent $68 billion on international aid in 2023. And the Trump administration's actions are also affecting what is termed the President's Malaria Initiative, an organization also founded by former President Bush. Through the work of this entity, the U.S. had become the global leader in donating to anti-malaria programs and research. According to the New York Times, one of Trump's executive orders has led to two-thirds of the staff being let go from the Malaria Initiative. And by pulling out of the World Health Organization, Trump further diminishes the critical role the U.S. plays in combating neglected tropical diseases, such as leishmaniasis, river blindness, Dengue fever and trachoma. These preventable and mostly treatable infectious diseases affect millions of people in tropical regions of the world, causing severe health problems, including anemia, blindness, chronic pain, infertility and bodily disfigurement. Historically, despite the large burden imposed by neglected tropical diseases on many people, they've received a relatively small portion of resources for drug development and treatment distribution. U.S. aid agencies had been filling some of the void. Until now.